A new study shows that thymic stromal lymphopoietin (TSLP, a cytokine that promotes allergic inflammation) and basophils contribute to the pathogenesis of eosinophilic oesophagitis (EoE). These ...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "TSLP Inhibitors and TSLP Receptor Antagonists: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...

Thymic Stromal Lymphopoietin (TSLP) is a cytokine that is a key driver of the inflammatory response in major allergic and inflammatory diseases, such as asthma, where disruption of TSLP signaling has ...

Please provide your email address to receive an email when new articles are posted on . Patients with asthma saw a 23% reduction in FeNO with treatment. Most adverse events were mild, with no serious ...

Healthy brinchial tube and constricted bronchial tube with asthma CSJ117, formulated as an engineered powder in hard capsules for delivery to the lungs via dry powder inhaler, may be the first inhaled ...

The cytokine thymic stromal lymphopoietin (TSLP) has previously been linked to allergic inflammatory diseases in humans. Now, three recent studies have confirmed that TSLP is a key initiator of ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in. On September 30, Upstream Bio presented new structural and mechanistic data for its therapeutic candidate, verekitug, at the ...

Please provide your email address to receive an email when new articles are posted on . The treatment group had reductions in FeNO 1 week after a single dose. Reductions were significant compared with ...

Many children who get a severe skin rash develop asthma months or years later. Doctors call the progression from eczema to breathing problems the atopic march. Now scientists have uncovered what might ...

Nasdaq provides an interactive ETF information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have trouble ...

Upstream Bio is presenting at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, which highlights the company's commitment to disseminating important research and gaining ...